Optimal use of methotrexate: the advantages of tight control
Authors:
- J W J BijlsmaJBJ W J Bijlsma
- M E WeinblattMWM E Weinblatt
- 1 November 2007
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 66 (11) , 1409-1410
Abstract
The CAMERA study shows that using methotrexate in a tight control setting might lead to considerable improvement in disease activity in early rheumatoid arthritis See linked article p 1443.Keywords
This publication has 14 references indexed in Scilit:
- New therapies for treatment of rheumatoid arthritisThe Lancet, 2007
- Tight control in the treatment of rheumatoid arthritis: efficacy and feasibilityAnnals of the Rheumatic Diseases, 2007
- Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)Annals of the Rheumatic Diseases, 2007
- Regression to the mean using the disease activity score in eligibility and response criteria for prescribing TNF- inhibitors in adults with rheumatoid arthritisRheumatology, 2007
- The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentArthritis & Rheumatism, 2005
- Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trialThe Lancet, 2004
- Treating rheumatoid arthritis early: A window of opportunity?Arthritis & Rheumatism, 2002
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trialThe Lancet, 1999
- The Effectiveness of Early Treatment with “Second-Line” Antirheumatic DrugsAnnals of Internal Medicine, 1996